Amphastar Pharma (AMPH) Swings to Q3 Loss

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.07), versus $0.05 reported last year. Revenue for the quarter came in at $59.71 million, versus $59.32 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• MotorK names Roy Toren to board as Helen Protopapas resigns
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen